Angiotech Pharma warns of Q3 loss on lower revenue, stock sinks (Canadian Press)

Canadian Press - VANCOUVER - Shares in Angiotech Pharmaceuticals Inc. (TSX:ANP) fell 25 per cent Friday morning as the company warned of a third-quarter loss, blaming a delay in revenue from new medical products, and also trimmed its full-year outlook.